Eight Drug Companies Petition Against Guangdong Tender Results
This article was originally published in PharmAsia News
Eight pharma companies have appealed against the essential drug procurement results announced by Guangdong’s Longgang district government.
You may also be interested in...
FDA warns OHM Pharma for promoting topical formula containing homeopathic ingredients as teething product for infants. The firm also warned about drug and supplements GMP violations and was an easy target for FDA following release of draft guidance outlining its enforcement priorities.
Richard Pazdur, FDA's oncology chief, reiterates the breakthrough therapy designation is for agency-sponsor communication and not an investor tool.